NASDAQ · NNOX
NANO-X IMAGING financials
$0.6560+3.78%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $13.0M | $11.3M | $9.9M | $8.6M | $1.3M | $0.00 |
| Gross profit | -$12.8M | -$10.6M | -$6.6M | -$6.9M | -$1.5M | $0.00 |
| Gross margin | −98.2% | −94.0% | −66.6% | −80.2% | −116.0% | — |
| Operating income | -$78.2M | -$56.7M | -$62.6M | -$117.7M | -$61.6M | -$43.9M |
| Net income | -$75.0M | -$53.5M | -$60.8M | -$113.2M | -$61.8M | -$43.8M |
| Net margin | −576.1% | −474.3% | −613.6% | −1320.2% | −4739.1% | — |
| Diluted EPS | $-1.16 | $-0.91 | $-1.08 | $-2.17 | $-1.28 | $-1.23 |
| EBITDA | -$49.0M | -$45.0M | -$43.4M | -$55.3M | -$59.3M | -$43.7M |
| Operating cash flow | -$40.8M | -$36.6M | -$44.8M | -$43.4M | -$38.1M | -$21.6M |
| Free cash flow | -$45.0M | -$39.4M | -$48.1M | -$50.6M | -$61.2M | -$35.5M |
| Diluted shares | 64.8M | 58.7M | 56.4M | 52.2M | 48.2M | 35.7M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $49.2M | $39.3M | $56.4M | $38.5M | $66.6M | $213.5M |
| Short-term investments | $0.00 | $18.4M | $26.0M | $39.2M | $22.1M | — |
| Total debt | $3.3M | $3.1M | $3.5M | $11.8M | $52.2M | $0.00 |
| Total assets | $162.2M | $210.0M | $218.6M | $253.9M | $363.2M | $236.1M |
| Total liabilities | $22.4M | $20.9M | $23.1M | $37.3M | $71.0M | $5.4M |
| Shareholders' equity | $139.7M | $189.1M | $195.5M | $216.7M | $292.1M | $230.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology